|
SPC25 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.255200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.873200E-01 |
| Normal-vs-Stage2 |
1.364250E-01 |
| Normal-vs-Stage3 |
5.594800E-01 |
| Normal-vs-Stage4 |
8.485400E-01 |
| Stage1-vs-Stage2 |
4.204600E-03 |
| Stage1-vs-Stage3 |
4.356000E-01 |
| Stage1-vs-Stage4 |
9.083800E-01 |
| Stage2-vs-Stage3 |
5.636500E-02 |
| Stage2-vs-Stage4 |
2.386300E-02 |
| Stage3-vs-Stage4 |
4.886600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.406400E-01 |
| Normal-vs-AfricanAmerican |
2.716400E-01 |
| Normal-vs-Asian |
6.788400E-01 |
| Caucasian-vs-AfricanAmerican |
9.117800E-02 |
| Caucasian-vs-Asian |
6.745000E-01 |
| AfricanAmerican-vs-Asian |
3.061800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.129600E-01 |
| Normal-vs-Female |
5.994800E-01 |
| Male-vs-Female |
6.881400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.912200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.128600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.689800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.327600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.758700E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.823000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.442580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.154300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.867800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.262200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.844400E-01 |
| Classical-VS-Follicular |
1.614700E-04 |
| Classical-VS-Other |
8.831800E-02 |
| Classical-VS-Normal |
8.196600E-01 |
| Tall-VS-Follicular |
9.636200E-03 |
| Tall-VS-Other |
1.546030E-01 |
| Tall-VS-Normal |
8.235000E-01 |
| Follicular-VS-Other |
9.556200E-01 |
| Follicular-VS-Normal |
1.357230E-01 |
| Other-VS-Normal |
1.896430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.684600E-01 |
| Normal-vs-N1 |
6.207000E-01 |
| N0-vs-N1 |
8.921800E-01 |
|
|
